Screening of the Salmonella paratyphi A CMCC 50973 strain outer membrane proteins for the identification of potential vaccine targets

Molecular Medicine Reports

Volumn 5, Issue 1, 2012, Pages 78-83

  Yang, Tian Ci ^b   Ma, Xian Cang ^c   Liu, Fan ^b   Lin, Li Rong ^b   Liu, Li Li ^b   Liu, Gui Li ^b   Tong, Man Li ^b   Fu, Zuo Gen ^b   Zhou, Lei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Immunogenicity; Immunoprotection; Outer membrane protein; Salmonella paratyphi A; Vaccine

Indexed keywords

ANTISERUM; LONG CHAIN FATTY ACID TRANSPORT PROTEIN PRECURSOR; MALTOPORIN PRECURSOR; NEW OUTER MEMBRANE PROTEIN PREDICTED BACTERIAL PORIN; OUTER MEMBRANE INVASION PROTEIN; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN; TOLC PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SCREENING; IMMUNITY; IN VITRO STUDY; LD 50; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; SALMONELLA PARATYPHI;

ANIMALS; ANTIBODIES; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SALMONELLA PARATYPHI A; SALMONELLA VACCINES;

MUS; SALMONELLA PARATYPHI;

EID: 84855232996     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.587     Document Type: Article

References (22)

1. Woods CW, Murdoch DR, Zimmerman MD, et al.: Emergence of Salmonella enterica serotype paratyphi A as a major cause of enteric fever in Kathmandu, Nepal. T Roy Soc Trop Med H 100: 1063-1067, 2006. (Pubitemid 44309209)
2. Ochiai RL, Wang XY, von Seidlein L, et al.: Salmonella paratyphi A rates, Asia. Emerg Infect Dis 11: 1764-1766, 2005. (Pubitemid 41628360)
3. Imran ZP, Zaidi A, Siddiqui AA, Nair S and Ahmad A: Molecular and epidemiological analysis of multidrug-resistant Salmonella paratyphi A obtained from different regions of Pakistan. Pak J Bot 42: 2941-2947, 2010.
4. Crump JA and Mintz ED: Global trends in typhoid and paratyphoid fever. Clin Infect Dis 50: 241-246, 2010.
5. Khanal B, Sharma SK, Amatya R and Poudyal N: Salmonella Typhi and Paratyphi A in Eastern Nepal-trends in antimicrobial resistance. Int J Infect Dis 12: e107-e109, 2008.
6. Uto T, Tsujimura K, Uchijima M, et al.: A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70. Fems Immunol Med Mic 61: 189-196, 2011.
7. Serpa JA, Valayam J, Musher DM, Rossen RD, Pirofski LA and Rodriguez-Barradas MC: V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clin Vaccine Immunol 18: 362-366, 2011.
8. Wang JC, Ouyang YS, Wang SJ, et al.: Construction and expression of nucleic acid vaccine pVAX1-h-alpha S1-140 coding human alpha-synuclein. Neural Regen Res 3: 1372-1375, 2008.
9. Findlow J, Borrow R, Snape MD, et al.: Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis 51: 1127, 2010.
10. Wooldridge KG and Williams PH: Sensitivity of Escherichia coli to cloacin DF13 involves the major outer membrane protein OmpF. J Bacteriol 173: 2420-2424, 1991.
11. Li H, Xiong XP, Peng B, et al.: Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach. J Proteome Res 8: 4342-4349, 2009.
12. Begier EM, Burwen DR, Haber P, Ball R and Vaccine Adverse Event Reporting System Working Group: Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002. Clin Infect Dis 38: 771-779, 2004.
13. Konadu E, Shiloach J, Bryla DA, Robbins JB and Szu SC: Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect Immun 64: 2709-2715, 1996. (Pubitemid 26226837)
14. Konadu EY, Lin FY, Ho VA, et al.: Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide- tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 68: 1529-1534, 2000. (Pubitemid 30108554)
15. Yang HH, Wu CG, Xie GZ, et al.: Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ 79: 625-631, 2001. (Pubitemid 32678448)
16. Parry C, Hien T and Dougan G: Review article: typhoid fever. N Engl J Med 347: 1770-1782, 2002.
17. Sinha S, Kosalai K, Arora S, et al.: Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 151: 2411-2419, 2005. (Pubitemid 40984314)
18. Maione D, Margarit I, Rinaudo CD, et al.: Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309: 148-150, 2005. (Pubitemid 40934997)
19. Li NQ, Bai JJ, Wu SQ, et al.: An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioides). Fish Shellfish Immun 25: 829-833, 2008.
20. Talebkhan Y, Mohammadi M, Razavi N and Sadeghi M: Over-expression of outer membrane protein 18, Omp18, as a putative vaccine against H-pylori infection. Helicobacter 13: 468-469, 2008.
21. Qian RH, Xiao ZH, Zhang CW, et al.: A conserved outer membrane protein as an effective vaccine candidate from Vibrio alginolyticus. Aquaculture 278: 5-9, 2008.
22. Gupta VK, Rout PK and Vihan VS: Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M. Res Vet Sci 82: 305-313, 2007. (Pubitemid 46584418)